Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials!!

Clinical Trial 7336

Jonesboro, AR 72401

Study Summary:

A clincal study to assess the effectiveness and safety of Ocrelizumab in combination with Methotrexate compared with Infliximab plus Methotrexate in patients with active Rheumatoid Arthritis currently responding inadequately to Etanercept or Adalimumab

Qualified Participants Must:

• *Age ≥ 18 years *Current treatment for RA on an outpatient basis *Active disease *Currently receiving 50 mg etanercept subcutaneously (SC) every week or 40 mg adalimumab SC every other week. *Considered by Investigator to be a primary non-responder to their first anti-TNFα treatment for efficacy reasons

Qualified Participants May Receive:

Compensation for their time and travel.

Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.